Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'"
J Am Acad Dermatol. 2021 Sep;85(3):e173-e174.
doi: 10.1016/j.jaad.2021.02.072.
Epub 2021 Mar 4.
1 Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: a.l.bosma@amsterdamumc.nl.
2 Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
3 Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
4 Department of Dermatology, Amsterdam Public Health, Immunity and Infections, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.